<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.moneycontrol.com/news/business/stocks/unichem-laboratories-share-price-gains-8-on-usfda-nod-for-atenolol-tablets-4669761.html"/>
    <meta property="og:site_name" content="Moneycontrol"/>
    <meta property="article:published_time" content="2019-11-25T00:00:00+00:00"/>
    <meta property="og:title" content="Unichem Laboratories share price gains 8% on USFDA nod for Atenolol tablets"/>
    <meta property="og:description" content="Atenolol tablets is indicated for the treatment of hypertension, to lower blood pressure."/>
  </head>
  <body>
    <article>
      <h1>Unichem Laboratories share price gains 8% on USFDA nod for Atenolol tablets</h1>
      <h2>Atenolol tablets is indicated for the treatment of hypertension, to lower blood pressure.</h2>
      <address><time datetime="2019-11-25T00:00:00+00:00">25 Nov 2019</time> by <a rel="author">Moneycontrol News</a></address>
      <p><a href="http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/unichemlaboratories/UL02">Unichem Laboratories</a> share price gained 8 percent in early trade on November 25 after the company received approval from USFDA for Atenolol Tablets USP.</p>
      <p>The company has received ANDA approval for its Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg. from the United States Food and Drug Administration (USFDA) to market a generic version of TENORMIN (Atenolol) Tablets, 25 mg, 50 mg, and 100 mg, of Alvogen Malta Operations Ltd.</p>
      <p>Atenolol tablets are indicated for the treatment of hypertension, to lower blood pressure.</p>
      <p>The product will be commercialized from company's Ghaziabad plant.</p>
      <p>At 0927 hrs, Unichem Laboratories was quoting at Rs 159, up Rs 6.30, or 4.13 percent on the BSE.</p>
      <p>The share touched its 52-week high of Rs 227 and its 52-week low of Rs 141.75 on 30 October 2018 and 15 November 2019, respectively.</p>
      <p>Currently, it is trading 29.96 percent below its 52-week high and 12.17 percent above its 52-week low.</p>
    </article>
  </body>
</html>